In the study by Rosario et al., the presence of ADAs (either persistently or transiently) was found to increase VDZ CLL by only 12%, a statistically significant but clinically insignificant effect [11]. The gene discussed is AGPS; the disease is B-cell chronic lymphocytic leukemia.